Insider Shareholders with Direct Ownership of Neurocrine Biosciences Inc (NBIX)
This section provides a comprehensive overview of the insiders with direct ownership of Neurocrine Biosciences Inc (NBIX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
NEUROCRINE BIOSCIENCES INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Kevin Charles Gorman
Chief Executive Officer |
481,198 | 555,302 | 514,596 $74.8 Million | 21 |
Feb 13, 2024
Reduced 0.55%
|
|
Haig P. Bozigian
Chief Development Officer |
0 | 6,803 | 157,651 $22.9 Million | 3 |
Feb 08, 2021
Reduced 1.02%
|
|
Kyle Gano
Chief Business Development Off |
103,266 | 144,923 | 135,166 $19.7 Million | 18 |
Feb 13, 2024
Reduced 0.99%
|
|
Gary A Lyons
Director |
60,530 | 90,430 | 119,047 $17.3 Million | 21 |
Jul 16, 2024
Reduced 0.78%
|
|
Dimitri E. Grigoriadis
Chief Research Officer |
5,000 | 13,570 | 82,273 $12 Million | 5 |
Oct 07, 2021
Reduced 5.73%
|
|
William H Rastetter
Director |
60,000 | 33,009 | 51,741 $7.53 Million | 10 |
Jan 02, 2024
Reduced 17.59%
|
|
Malcolm Lloyd Smith
Chief Integration Officer |
49,946 | 85,361 | 42,337 $6.16 Million | 19 |
Feb 08, 2023
Reduced 1.63%
|
|
Eric Benevich
Chief Commercial Officer |
278,651 | 330,396 | 40,778 $5.93 Million | 40 |
Apr 15, 2024
Reduced 23.59%
|
|
Darin Lippoldt
Chief Legal Officer |
114,028 | 168,517 | 39,740 $5.78 Million | 43 |
Jul 16, 2024
Reduced 14.98%
|
|
Richard F Pops
Director |
74,199 | 72,100 | 31,611 $4.6 Million | 14 |
May 17, 2024
Reduced 6.23%
|
|
Matt Abernethy
Chief Financial Officer |
30,900 | 80,545 | 31,528 $4.59 Million | 21 |
Jul 16, 2024
Reduced 2.78%
|
|
Stephen A Sherwin
Director |
89,199 | 92,556 | 26,504 $3.85 Million | 10 |
May 29, 2024
Reduced 36.14%
|
|
Eiry Roberts
Chief Medical Officer |
100,000 | 163,860 | 23,716 $3.45 Million | 25 |
Feb 13, 2024
Reduced 4.49%
|
|
Julie Cooke
Chief Human Resources Officer |
48,900 | 98,030 | 18,202 $2.65 Million | 33 |
Jul 16, 2024
Reduced 4.71%
|
|
Jude Onyia
Chief Scientific Officer |
0 | 14,052 | 13,128 $1.91 Million | 7 |
Feb 13, 2024
Reduced 9.84%
|
|
Ingrid Delaet
Chief Regulatory Officer |
19,864 | 25,360 | 6,607 $960,922 | 27 |
Jul 16, 2024
Reduced 11.99%
|
|
David W. Boyer
Chief Corp. Affairs Officer |
0 | 41,475 | 4,895 $711,928 | 15 |
Feb 13, 2024
Reduced 14.88%
|
|
George J Morrow
Director |
44,199 | 40,000 | 4,199 $610,702 | 3 |
May 17, 2024
Added 50.0%
|
|
Johanna Mercier
Director |
2,100 | 0 | 2,100 $305,424 | 1 |
May 17, 2024
Added 50.0%
|
|
Leslie V Norwalk
Director |
10,100 | 9,106 | 994 $144,567 | 4 |
May 17, 2024
Reduced 52.67%
|
|
Shalini Sharp
Director |
2,100 | 1,106 | 994 $144,567 | 2 |
May 17, 2024
Reduced 52.67%
|